Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6Q0K

Structure of a MAPK pathway complex

Summary for 6Q0K
Entry DOI10.2210/pdb6q0k/pdb
EMDB information20551
DescriptorSerine/threonine-protein kinase B-raf, 14-3-3 protein zeta/delta (2 entities in total)
Functional Keywordstransferase, signaling protein-transferase complex, signaling protein/transferase
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains4
Total formula weight234199.81
Authors
Park, E.,Rawson, S.,Jeon, H.,Eck, M.J. (deposition date: 2019-08-01, release date: 2019-10-09, Last modification date: 2024-11-06)
Primary citationPark, E.,Rawson, S.,Li, K.,Kim, B.W.,Ficarro, S.B.,Pino, G.G.,Sharif, H.,Marto, J.A.,Jeon, H.,Eck, M.J.
Architecture of autoinhibited and active BRAF-MEK1-14-3-3 complexes.
Nature, 575:545-550, 2019
Cited by
PubMed Abstract: RAF family kinases are RAS-activated switches that initiate signalling through the MAP kinase cascade to control cellular proliferation, differentiation and survival. RAF activity is tightly regulated and inappropriate activation is a frequent cause of cancer; however, the structural basis for RAF regulation is poorly understood at present. Here we use cryo-electron microscopy to determine autoinhibited and active-state structures of full-length BRAF in complexes with MEK1 and a 14-3-3 dimer. The reconstruction reveals an inactive BRAF-MEK1 complex restrained in a cradle formed by the 14-3-3 dimer, which binds the phosphorylated S365 and S729 sites that flank the BRAF kinase domain. The BRAF cysteine-rich domain occupies a central position that stabilizes this assembly, but the adjacent RAS-binding domain is poorly ordered and peripheral. The 14-3-3 cradle maintains autoinhibition by sequestering the membrane-binding cysteine-rich domain and blocking dimerization of the BRAF kinase domain. In the active state, these inhibitory interactions are released and a single 14-3-3 dimer rearranges to bridge the C-terminal pS729 binding sites of two BRAFs, which drives the formation of an active, back-to-back BRAF dimer. Our structural snapshots provide a foundation for understanding normal RAF regulation and its mutational disruption in cancer and developmental syndromes.
PubMed: 31581174
DOI: 10.1038/s41586-019-1660-y
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (6.8 Å)
Structure validation

235666

PDB entries from 2025-05-07

PDB statisticsPDBj update infoContact PDBjnumon